Emerald Mutual Fund Advisers Trust’s PTC Therapeutics PTCT Stock Holding History

Emerald Mutual Fund Advisers Trust’s Portfolio PTCT Stock Details PTCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-85,696	Closed	-$3.82M	–	327
2020 Q1	$3.82M	Sell	85,696 -289,150	-77%	-$14.6M	0.24%	114
2019 Q4	$18M	Buy	374,846 +11,434	+3%	+$486K	0.74%	47
2019 Q3	$12.3M	Buy	363,412 +8,664	+2%	+$377K	0.54%	67
2019 Q2	$16M	Buy	354,748 +80,036	+29%	+$3.16M	0.63%	54
2019 Q1	$10.3M	Buy	274,712 +67,359	+32%	+$2.26M	0.41%	87
2018 Q4	$7.12M	Hold	207,353	–	–	0.33%	103
2018 Q3	$9.75M	Buy	+207,353	New	+$8.58M	0.33%	110
2016 Q1	–	Sell	-112,678	Closed	-$3.65M	–	275
2015 Q4	$3.65M	Buy	+112,678	New	+$3.32M	0.19%	137

Other funds holding PTCT

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's PTCT Position: Q2 2020 in Review

Emerald Mutual Fund Advisers Trust sold out of PTC Therapeutics (PTCT) in Q2 2020, closing a stake of 85,696 shares — an estimated $3.82M sold.

Emerald Mutual Fund Advisers Trust first reported a position in PTCT in Q4 2015 and held it in 8 quarters. The position peaked at $18M in Q4 2019. 202 funds tracked by Wall St. Rank hold PTCT as of Q2 2020.

Emerald Mutual Fund Advisers Trust reported no remaining PTC Therapeutics position as of Q2 2020 after selling out during the quarter.
Emerald Mutual Fund Advisers Trust sold 85,696 PTC Therapeutics shares in Q2 2020, an estimated $3.82M.
Emerald Mutual Fund Advisers Trust first reported a position in PTC Therapeutics in Q4 2015 and held it in 8 quarters.
Emerald Mutual Fund Advisers Trust's PTC Therapeutics position peaked at $18M in Q4 2019.
202 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2020.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q2 2020, filed 28 Jul 2020.